Hans Henskens joined Glycostem’s leadership team as Chief Quality Officer/QP in January 2020, bringing nearly 30 years of experience in the pharmaceutical industry to his role. During his career Hans played important roles such as the head of quality at Synthon Biopharmaceuticals BV, building the company’s quality system; and as director of quality at PharmaCell BV, which was later acquired by Lonza Netherlands BV. Hans has extensive experiences in the field of cell therapy and virus transduced cell therapy products and has led several EMA and FDA inspections for different companies. Hans earned his PhD in molecular biology from the University of Amsterdam and has been acting as a Qualified Person within the European Union for the past 15 years.
Hans Henskens PhD
Chief Quality Officer/QP